Skip to content

NuSkin Enterprises NUS Net debt / EBITDA

Net debt / EBITDA at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
-1.6×-0.3×
Lifevantage Corporation logo
Lifevantage CorporationLFVN
-0.2×-0.1×
USANA Health Sciences logo
USANA Health SciencesUSNA
-2×0.0×
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
4.6×
Herbalife logo
HerbalifeHLF
2.8×-0.9×
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
5.1×+3.6×

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-34.9%

Where this comes from

Calculated from NuSkin Enterprises’s reported figures.

Based on the most recent quarter.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's net debt / EBITDA?
NuSkin Enterprises (NUS) reported net debt / EBITDA of 0.8× in Q1 2026.
What is the long-term trend for NuSkin Enterprises's net debt / EBITDA?
Over 4 years (2020 to 2025), NuSkin Enterprises's net debt / EBITDA has grown at a 19.0% compound annual growth rate (CAGR), from 0.3× to 0.6×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.